Dr. Khalil Eldeeb to be published, selected for fellowship and joins national faculty

BUIES CREEK, North Carolina – Dr. Khalil Eldeeb, assistant professor of pharmacology, has been selected for The Maya Angelou Center for Health Equity (MACHE) Center of Excellence and Health Equity Research Opportunity (HERO) Fellowship.  The program is a research collaboration program designed to provide opportunities to establish sustained interaction with ongoing health equity projects within the Maya Angelou Center for Health Equity (MACHE) and affiliated Wake Forest School of Medicine departments and centers.

The program will provide Dr. Eldeeb with beneficial information regarding NIH Diversity Supplement and will enable Dr. Eldeeb to continue his collaboration with the researchers at Wake Forest with access to lab facilities and seminars as an adjunct faculty at Wake Forest school of Medicine. The fellowship begins June 1, 2016 at Wake Forest School of Medicine.

Dr. Eldeeb’s research aims align with the goals of MACHE and HERO.  Dr. Eldeeb’s long term research interests involve development of a comprehensive understanding of how cannabinoid receptors signal and how their signaling interacts with other cellular processes. The goal is to explore the role of the endocannabinoid signaling system in neurological diseases leading to the development of new preventive and therapeutic measures against such diseases. The fellowship will provide him the opportunity to collaborate with Dr. Allyn Howlett, one of the most eminent researchers in the field, who helped with identification of the cannabinoid receptors in brain.  Dr. Eldeeb has been investigating cannabinoid effects since 2007, for his doctoral studies at University of Nottingham, UK and then as a postdoctoral fellow at Wake Forest School of Medicine.

Dr. Eldeeb was among the first group to join the Postdoctoral Research, Instruction, and Mentoring Experience (PRIME) program at Wake Forest University supported by Institutional Research and Academic Career Development Awards (IRACDA) from The National Institute of General Medical Sciences (NIGMS) to develop highly-skilled biomedical scientists to teach the next generation of clinical researchers and allied health professionals. During his time at Wake Forest University, Dr. Eldeeb’s research received the best presentation award twice at the 6th European Workshop on Cannabinoid Research (Ireland April 2013) and at the 24th Annual International Cannabinoid Research Society (ICRS) Symposium on the Cannabinoids Research (Italy 2014).

“We are honored to have Dr. Eldeeb among the 2016 HERO Fellows,” said Dr. Michael P. Mahalik, senior associate dean for academic affairs and research at Campbell.  “We know this program will continue to foster excellence in Dr. Eldeeb’s research as well as his skills in grant writing and publications.”

Dr. Eldeeb’s recent research data was accepted for publication in a special issue from the Journal of Basic and Clinical Physiology and Pharmacology, and Dr.Eldeeb recently joined the National Board of Osteopathic Medical Examiners (NBOME) as National Faculty in the department of Foundational Biomedical Sciences- division of Pharmacology.